Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases.

Rogério Serafim Parra Sandro da Costa FerreiraVanessa Foresto MachadoCintia Maura Caseiro NigroJosé Joaquim Ribeiro da RochaLuiz Ernesto de Almeida TronconOmar Feres

Published in: Journal of clinical medicine (2023)

Brazilian IBD patients reported high rates of failure to dispense biological drugs by the national healthcare system within one year. Our data highlight the need for improvement in this system for the correct supply of medication to avoid treatment failure and relapse.

Keyphrases

end stage renal disease
healthcare
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
primary care
peritoneal dialysis
electronic health record
emergency department
machine learning
combination therapy
deep learning
artificial intelligence